Livingston Street Capital
Sponsor Overview
Livingston Street Capital is a NYC-based DST sponsor founded around 2015 specializing in mission-critical office, healthcare, and industrial real estate leased to single tenants on long-term triple-net leases. The 4 full-cycle DSTs delivered ~8.5% implied AAR, 1.38x EM, over 4.2-year holds with 100% success rate (no losses). Livingston's niche is single-tenant specialty real estate where the tenant's operational dependence on the property creates renewal/credit strength. Deals include healthcare facilities (University of Kansas Health, Bio-reference Labs), office (FAUR), and industrial (AM Mission Critical).
Sponsor Notes
- Mission-critical single-tenant specialty real estate
- Long-term triple-net leases with credit tenants
- Healthcare, office, industrial — tenant-operational-critical assets
- Smaller firm with 100% success rate on 4 full-cycle deals
Sponsor Overview
Firm Name
Livingston Street Capital
Headquarters
New York, NY
Year Founded
2015
Assets Under Management (AUM)
$500M+
Preferred Sponsor
No
Performance
Full-Cycle DSTs
4
Average Annual Return
8.52%
Average Equity Multiple
1.38x
Average Hold Period
4.21 Years
Success Rate
100.00%
The information presented on this page regarding this investment sponsor is provided solely for educational and informational purposes. It is intended to help readers develop a general understanding of the sponsor and its offerings, and is not tailored to the financial situation, objectives, or needs of any particular individual or entity.
Nothing on this page — including any sponsor descriptions, background information, market commentary, charts, examples, performance data, or analyst notes — constitutes investment, legal, tax, or accounting advice, nor a recommendation, endorsement, offer, or solicitation to buy, sell, or hold any security or pursue any investment strategy. The information, views, and opinions expressed (including those contained in any analyst notes or commentary) reflect the perspective of the author at the time of publication, are subject to change without notice, and should not be relied upon as the basis for any investment decision.
The presence of a sponsor profile on this page does not indicate any business, financial, ownership, or contractual affiliation between Baker 1031 Investments and the sponsor, nor does it constitute an endorsement of the sponsor or any of its offerings.
Any performance data shown on this page — including, without limitation, full-cycle results, internal rate of return (IRR), equity multiple, average annual return, hold period, cash-on-cash return, or distribution history — is self-reported by the sponsor and sourced from the sponsor's Private Placement Memorandums (PPMs) and related offering documents. Baker 1031 Investments has not independently verified the accuracy or completeness of this information and cannot guarantee its validity. Although we make every effort to accurately transcribe sponsor-reported figures, errors are possible. Please verify any figure directly with the sponsor before relying on it.
Past performance is not indicative of future results. Performance data reflects outcomes of prior offerings and should not be expected to recur in current or future investments, which may result in partial or total loss of principal.
Before making any investment decision, you should consult with your own qualified financial, legal, and tax advisors and carefully review all relevant offering documents, including the applicable PPM in its entirety. Investments offered by sponsors profiled on this site involve risk, including the potential loss of principal, and may not be suitable for all investors.
